Bespoke treatment: drivers beware!

Abstract excerpt

Significant progress has been made in the identification of molecular targets and targeted therapy is becoming a realistic option for patients with tumors for which potential driver mutations are identified. We present a case that highlights that the identification of a potential driver mutation does not confirm it as a key mutational event in every case and emphasizes the need for ongoing research to enable...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Sulfonamides
• Share to Carcinoma, Pancreatic Ductal
• Share to Fatal Outcome